List of Marker Gene Technologies, Inc. patents

List of Marker Gene Technologies, Inc. patents

List of Anulex patents

List of Cardica, Inc. patents

List of Babcock & Wilcox patents

List of AI educational game companies

List of SBIR/STTR awards granted to Origene Technologies

Patents where

Current Assignee

Name

is

‌

Marker Gene Technologies, Inc.

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 9610358 Targeted pharmacological chaperones	Patent 9610358 was granted and assigned to Marker Gene Technologies, Inc. on April, 2017 by the United States Patent and Trademark Office.	‌ Marker Gene Technologies, Inc.	‌ Marker Gene Technologies, Inc.		United States Patent and Trademark Office	9610358	April 4, 2017
	‌ US Patent 10401361 Intracellular organelle peptide targeted enzyme substrates	Patent 10401361 was granted and assigned to Marker Gene Technologies, Inc. on September, 2019 by the United States Patent and Trademark Office.	‌ Marker Gene Technologies, Inc.	‌ Marker Gene Technologies, Inc.		United States Patent and Trademark Office	10401361	September 3, 2019
	‌ US Patent 9677115 Enzyme substrates for visualizing acidic organelles	Patent 9677115 was granted and assigned to Marker Gene Technologies, Inc. on June, 2017 by the United States Patent and Trademark Office.	‌ Marker Gene Technologies, Inc.	‌ Marker Gene Technologies, Inc.		United States Patent and Trademark Office	9677115	June 13, 2017
	‌ US Patent 9925271 Targeted pharmacological chaperones	Patent 9925271 was granted and assigned to Marker Gene Technologies, Inc. on March, 2018 by the United States Patent and Trademark Office.	‌ Marker Gene Technologies, Inc.	‌ Marker Gene Technologies, Inc.		United States Patent and Trademark Office	9925271	March 27, 2018
	‌ US Patent 8450054 Modified	Patent 8450054 was granted and assigned to Marker Gene Technologies, Inc. on May, 2013 by the United States Patent and Trademark Office.		‌ Marker Gene Technologies, Inc.		United States Patent and Trademark Office	8450054	May 28, 2013
	‌ US Patent 9841426 Intracellular organelle peptide targeted enzyme substrates	Patent 9841426 was granted and assigned to Marker Gene Technologies, Inc. on December, 2017 by the United States Patent and Trademark Office.	‌ Marker Gene Technologies, Inc.	‌ Marker Gene Technologies, Inc.		United States Patent and Trademark Office	9841426	December 12, 2017
	‌ US Patent 7723502 Modified	Patent 7723502 was granted and assigned to Marker Gene Technologies, Inc. on May, 2010 by the United States Patent and Trademark Office.		‌ Marker Gene Technologies, Inc.		United States Patent and Trademark Office	7723502	May 25, 2010
	‌ US Patent 8206961 Modified	Patent 8206961 was granted and assigned to Marker Gene Technologies, Inc. on June, 2012 by the United States Patent and Trademark Office.		‌ Marker Gene Technologies, Inc.		United States Patent and Trademark Office	8206961	June 26, 2012
	‌ US Patent 10543282 Targeted peptide conjugates	Patent 10543282 was granted and assigned to Marker Gene Technologies, Inc. on January, 2020 by the United States Patent and Trademark Office.	‌ Marker Gene Technologies, Inc.	‌ Marker Gene Technologies, Inc.		United States Patent and Trademark Office	10543282	January 28, 2020
	‌ US Patent 8716558 Method of altering glycosylation of proteins in response to nojirimycin glucuronide in a plant cell expressing glucuronidase	Patent 8716558 was granted and assigned to Marker Gene Technologies, Inc. on May, 2014 by the United States Patent and Trademark Office.		‌ Marker Gene Technologies, Inc.		United States Patent and Trademark Office	8716558	May 6, 2014

10 results

0 selected

10 results

0 selected